Bayer and Curadev sign research collaboration and license agreement for STING antagonists Medical Dialogues Bureau25 March 2020 5:45 AM GMTBerlin & New Delhi: Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, has announced a research collaboration and license agreem...
Bayer, Nuvisan ink pact to create new research unit in Berlin Medical Dialogues Bureau14 Feb 2020 5:00 AM GMTThe strategic partnership will lay the foundation for a brand-new research entity to be established by Nuvisan in Berlin. At the same time, it will...
Bayer makes EMA application for a pre-filled syringe to administer eye medication Eylea MD bureau2 Feb 2020 4:30 AM GMTBerlin: Bayer has submitted an application to the European Medicines Agency (EMA) for a pre-filled syringe to administer Eylea® (aflibercept solution f...
Drugmajors slash prices by 53pc for China bulk-buy program eligibility Medical Dialogues Bureau20 Jan 2020 4:30 AM GMTBeijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest biddin...
German drug assessment body not convinced by Bayer's cancer drug Vitrakvi Medical Dialogues Bureau19 Jan 2020 4:00 AM GMTFrankfurt: Germany's drug assessment body said that data provided by Bayer on its precision cancer drug Vitrakvi did not provide clear enough evidence ...
